金融界2月12日消息，有投资者在互动平台向华特达因提问：范总，您好！公司在儿童医药领域，尤其AD滴剂，绝对遥遥领先。可是您也知道未来出生率下降是一定的，而老龄化逐年增加，那公司有没有在老年人涉及的医药领域发展？比如研发心脑血管类疾病和涉及高血压、高血糖、高血脂等方面药物？再或者收购一些这类有一定医药技术的企业？有没有考虑？麻烦范总回复一下，十分感谢！
公司回答表示：公司致力于“成为儿童保健和治疗领域的领军企业”，公司将坚定不移执行发展战略，并将产品及人群向大中童市场丰富和延伸，专注于儿童制药及健康领域。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.